Reinovax Biologics Co., LTD
4 clinical trials · Sponsor
◉ Watch Reinovax Biologics Co., LTD
| Record | Firm | Date |
|---|---|---|
| PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months (NCT07333352) | Reinovax Biologics Co., LTD | 2025-09-11 |
| Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years (NCT06675032) | Reinovax Biologics Co., LTD | 2024-04-27 |
| Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT06678620) | Reinovax Biologics Co., LTD | 2024-04-20 |
| Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older (NCT06678607) | Reinovax Biologics Co., LTD | 2023-11-19 |
Track Reinovax Biologics Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.